High-efficiency CRISPR gene editing products, including Cas proteins and RNAs, ensure seamless, effective gene editing for your cell and gene therapies.


uBriGene offers CRISPR gene editing products, including Cas proteins and mRNAs such as spCas9, Cas12a, Cas13a, and Cas14.
These gene editing proteins and mRNAs are manufactured under GMP standards and fully tested for quality and gene editing efficiency.
A comprehensive range of gene editing products, including spCas9, Cas12a, Cas13a, and Cas14.
Traceable and complete documentation.
GMP-grade products to support gene modification in clinical cell and gene therapies.
Full-service solutions, including RNP and LNP formulation with your guide RNA.
Active FDA DMF #29884 (Ubri-Cas9 protein for CRISPR)
| Product Name | Catalog Number | Description | Grade | Price |
|---|---|---|---|---|
| Ubri-Cas9 | 1308Ubri-Cas9 | spCas9 Protein, high quality and tested for efficient gene editing | ☑Research ☑GMP |
|
| Ubri-Cas12a | 1308Ubri-Cas12a | Cas12a Protein, high quality and tested for efficient gene editing | ☑Research ☑GMP |
|
| Ubri-Cas13a | 1308Ubri-Cas13a | Cas13a Protein, high quality and tested for efficient gene editing | ☑Research ☑GMP |
|
| Ubri-Cas14 | 1308Ubri-Cas14 | Cas14 Protein, high quality and tested for efficient gene editing | ☑Research ☑GMP |
Please Inquire |
| spCas9-mRNA | spCas9-mRNA | Cas9 mRNA, ultra-pure, tested for high gene editing efficiency | ☑Research ☑GMP |
|
| Cas12a-mRNA | Cas12a-mRNA | Cas12a mRNA, ultra-pure, tested for high gene editing efficiency | ☑Research ☑GMP |
|
| Cas13a-mRNA | Cas13a-mRNA | Cas13a mRNA, ultra-pure, tested for high gene editing efficiency | ☑Research ☑GMP |
|
| Cas14-mRNA | Cas14-mRNA | Cas14 mRNA, ultra-pure, tested for high gene editing efficiency | ☑Research ☑GMP |
Cas proteins & Cas mRNAs
Manufactured under GMP standards
Fully tested for high gene editing efficiency
RNP and LNP formulation services


uBriGene has developed sgRNA in vitro transcription technology, which is more scalable and cost-effective than chemical synthesis.
uBriGene offers comprehensive CRISPR gene editing tools for both discovery research and clinical programs. Our ready-to-use Cas proteins and mRNAs, combined with our groundbreaking sgRNA in vitro transcription technology, support all your gene editing needs.
For homology-directed repair, the following donor DNA can be provided: AAV, plasmids, linear double-stranded DNA (DS DNA), closed-end linear DS DNA, linear single-stranded DNA (SS DNA), and circular SS DNA.

CRISPR Cas proteins are recombinant proteins purified from E. coli using a series of chromatography methods. The untagged Cas proteins are concentrated by TFF and sterile filled into vials, ready for gene editing in clinical therapies.

Fig. 1. Diagram of CRISPR Cas protein purification process.
Ultra-pure Cas proteins are produced using our optimized protein purification processes. The following data shows the elution profile of Cas9 using a chromatographic method.

Fig. 2. Cas9 elution profile during chromatographic purification.
The activity of Cas9 proteins was analyzed using an in vitro assay by cutting linear DNA in the presence of sequence-specific guide RNA. Cas9 proteins from uBriGene demonstrated higher activity than those from both competitors.

Fig. 3. Cas9 proteins from uBriGene and two competitors were tested for guide RNA-mediated, DNA sequence-specific cutting in an in vitro assay.
CRISPR Cas proteins are recombinant proteins purified from E. coli using a series of chromatography methods. The untagged Cas proteins are concentrated by TFF and sterile filled into vials, ready for gene editing in clinical therapies.
Our off-the-shelf lentivirus packaging plasmids are manufactured and released in strict compliance with the highest regulatory standards. A certificate of analysis will be provided with each of the GMP grade lentiviral packaging plasmids.
| Test Items | Method | |
|---|---|---|
| Appearance | Visual inspection | |
| pH | pH measurement | |
| Concentration | UV, Spectrophotometry | |
| Identity | Restriction analysis | Gel electrophoresis |
| Target sequence analysis* | Sanger sequencing | |
| Purity | A260/A280 | UV, Spectrophotometry |
| Supercoiled plasmid ratio | HPLC | |
| Residuals | Residual E. Coli DNA | qPCR |
| Residual E. Coli RNA | Gel electrophoresis/HPLC | |
| Residual E. Coli protein | ELISA | |
| Safety | Endotoxin | Gel-clot assay |
| Sterility | Membrane filtration method | |
Redefining RNA Therapeutics: GMP RNA-LNP Manufacturing You Can Trust
Learn more about our CAR-T CDMO manufacturing for high-quality therapies.
Unlock safer regenerative therapies with Genome-Safe iPSC RPM for clinical success.
Explore RNA drug development fundamentals and the vital role of IVT in manufacturing.
Yes. uBriGene offers Cas proteins and Cas mRNAs in research-grade and GMP-grade formats for CRISPR gene-editing applications. Available products include SpCas9, Cas12a, Cas13a, and Cas14, with quality-control testing and traceable documentation to support development and regulated manufacturing programs. uBriGene also provides RNP and LNP formulation services using gene-specific guide RNA.
Yes. Cas mRNA and sgRNA can be co-formulated in LNPs as a non-viral gene-editing delivery strategy. uBriGene has tested Cas9 mRNA and guide RNA formulated into LNPs and supports LNP formulation development using proprietary microfluidic technology. Formulation conditions can be optimized according to the RNA payload, lipid composition, target cells, and intended gene-editing application.
Cas proteins are CRISPR-associated enzymes that work with guide RNA to recognize and modify specific nucleic-acid sequences. Different Cas systems have different target-recognition and cleavage properties, making them suitable for applications such as DNA editing, RNA editing, and other CRISPR-based technologies.
uBriGene offers several CRISPR-associated proteins, including SpCas9, Cas12a, Cas13a, and Cas14, with selected Cas systems available in protein and mRNA formats. These products support different gene-editing and nucleic-acid engineering strategies, allowing developers to select a Cas system and delivery format according to the target, cell type, and intended application.
uBriGene produces Cas proteins as recombinant proteins using E. coli expression followed by chromatographic purification. The proteins are further concentrated using tangential flow filtration (TFF) and can be sterile filled for downstream gene-editing applications.
uBriGene's Cas proteins and mRNAs undergo quality-control testing appropriate to the product type, including characterization of identity, purity, concentration, and functional activity. GMP-grade materials are released with traceable documentation to support regulated development and manufacturing programs.
Cas protein provides the active gene-editing enzyme directly, while Cas mRNA is delivered into cells and translated to produce the Cas protein intracellularly. The appropriate format depends on the cell type, delivery method, desired duration of activity, and overall gene-editing strategy.
Yes. uBriGene provides CRISPR RNP formulation using Cas proteins and gene-specific sgRNA, as well as LNP formulation using RNA payloads such as Cas mRNA and guide RNA. Formulation development can be tailored to the RNA payload, Cas system, target cells, and intended gene-editing application.
uBriGene's CRISPR products and services support applications including gene knockout, targeted gene modification, cell engineering, iPSC research, and cell and gene therapy development. Cas proteins, Cas mRNA, sgRNA, RNP formulation, and LNP formulation can be selected according to the editing strategy, target, cell type, and delivery requirements.
A CRISPR ribonucleoprotein (RNP) is a complex formed by a Cas protein and guide RNA. The guide RNA directs the Cas enzyme to a target nucleic-acid sequence, enabling transient CRISPR-mediated editing without delivering DNA encoding the editing machinery.
Manufactured under GMP standards
Fully tested for high gene editing efficiency
RNP and LNP formulation services
